6-145735291-C-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_005670.4(EPM2A):​c.208G>C​(p.Glu70Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000218 in 1,484,874 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E70V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 1 hom. )

Consequence

EPM2A
NM_005670.4 missense

Scores

1
3
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 1.09

Publications

0 publications found
Variant links:
Genes affected
EPM2A (HGNC:3413): (EPM2A glucan phosphatase, laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018]
EPM2A-DT (HGNC:48990): (EPM2A divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03954661).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000311 (47/151106) while in subpopulation AMR AF = 0.00171 (26/15202). AF 95% confidence interval is 0.0012. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005670.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPM2A
NM_005670.4
MANE Select
c.208G>Cp.Glu70Gln
missense
Exon 1 of 4NP_005661.1O95278-1
EPM2A
NM_001018041.2
c.208G>Cp.Glu70Gln
missense
Exon 1 of 5NP_001018051.1O95278-2
EPM2A
NM_001368130.1
c.208G>Cp.Glu70Gln
missense
Exon 1 of 3NP_001355059.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPM2A
ENST00000367519.9
TSL:1 MANE Select
c.208G>Cp.Glu70Gln
missense
Exon 1 of 4ENSP00000356489.3O95278-1
EPM2A
ENST00000435470.2
TSL:1
c.208G>Cp.Glu70Gln
missense
Exon 1 of 5ENSP00000405913.2O95278-2
EPM2A
ENST00000638262.1
TSL:1
c.208G>Cp.Glu70Gln
missense
Exon 1 of 3ENSP00000492876.1O95278-5

Frequencies

GnomAD3 genomes
AF:
0.000311
AC:
47
AN:
151000
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000726
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00171
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000267
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000269
AC:
28
AN:
103996
AF XY:
0.000190
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000460
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000448
Gnomad OTH exome
AF:
0.000675
GnomAD4 exome
AF:
0.000207
AC:
276
AN:
1333768
Hom.:
1
Cov.:
30
AF XY:
0.000207
AC XY:
136
AN XY:
658398
show subpopulations
African (AFR)
AF:
0.0000371
AC:
1
AN:
26982
American (AMR)
AF:
0.000755
AC:
23
AN:
30474
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22886
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74920
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5118
European-Non Finnish (NFE)
AF:
0.000224
AC:
235
AN:
1048380
Other (OTH)
AF:
0.000312
AC:
17
AN:
54456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000311
AC:
47
AN:
151106
Hom.:
0
Cov.:
32
AF XY:
0.000325
AC XY:
24
AN XY:
73830
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41430
American (AMR)
AF:
0.00171
AC:
26
AN:
15202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3448
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5122
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10258
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000267
AC:
18
AN:
67526
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000731
Hom.:
0
Bravo
AF:
0.000468
ExAC
AF:
0.0000623
AC:
6

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
1
-
Inborn genetic diseases (1)
-
1
-
Lafora disease (1)
-
1
-
Progressive myoclonic epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
15
DANN
Benign
0.75
DEOGEN2
Benign
0.36
T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.66
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.62
T
M_CAP
Pathogenic
0.71
D
MetaRNN
Benign
0.040
T
MetaSVM
Uncertain
-0.099
T
MutationAssessor
Benign
0.20
N
PhyloP100
1.1
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-0.50
N
REVEL
Benign
0.24
Sift
Benign
0.080
T
Sift4G
Benign
0.30
T
Polyphen
0.99
D
Vest4
0.046
MutPred
0.36
Loss of helix (P = 0.0167)
MVP
0.94
MPC
0.24
ClinPred
0.11
T
GERP RS
2.6
PromoterAI
-0.010
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
gMVP
0.44
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs550455609; hg19: chr6-146056427; API